EXECUTIVE BRIEFING
Sensitivity, Specificity & Latency
The three system metrics every executive must understand when AI and advanced networks make decisions at machine speed. Why a high accuracy score is not enough, how the tradeoff between the three dials embeds a philosophy of risk, and a 90-day action plan for making every accepted failure mode explicit. Grounded in NIST AI RMF and CISA guidance, spanning healthcare, cyber, finance, and defense.
Request the briefing →
POSITION
The Patient Data Sovereignty Problem
The new wave of health AI platforms is technically impressive and fundamentally provider-centric. This piece argues the real question is architectural: should health intelligence live on infrastructure AI companies own, or on federated, edge-first infrastructure patients control? Covers the 98% of health that happens outside clinical settings, the 53 million caregivers both platforms overlook, and why efficiency gains for the existing machinery are not transformation.
Request the analysis →
FIELD NOTE
AI Tools and Your Patent Rights
Describing a novel invention to a consumer AI chatbot may start a disclosure clock, and in absolute-novelty jurisdictions it can cost you patent rights entirely. A practical, tool-by-tool look at how provider training and retention policies affect intellectual property, and the session protocols inventors and founders should adopt before their next AI conversation. Updated as vendor policies change.
Request the guide →